Healthcare Services APAC

APAC Hospice Care Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Hospice Care Market Industry Trends and Forecast to 2034: Segmented by (Setting, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $7.69 Bn Placeholder estimate
Estimate 2025 $8.35 Bn 22.8% of the global market
Projected 2034 $17.54 Bn 110.1% Adds $9.19 Bn over 9 forecast years
CAGR 2025–2034 8.6% Faster than 30% of 107 Healthcare Services markets here
Key players 5
  • APAC is 22.79% of the global market.
  • Among regions, the largest is North America at $19.20 Bn.
  • Fastest growing: APAC (this report) at 8.6% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$9.19 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Hospice Care Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $7.69 Bn — —
2025 (base) $8.35 Bn +$661.1 Mn —
2026 (forecast) $9.07 Bn +$718.0 Mn +8.6%
2027 (forecast) $9.85 Bn +$779.7 Mn +17.9%
2028 (forecast) $10.69 Bn +$846.8 Mn +28.1%
2029 (forecast) $11.61 Bn +$919.6 Mn +39.1%
2030 (forecast) $12.61 Bn +$998.7 Mn +51.1%
2031 (forecast) $13.70 Bn +$1.08 Bn +64.1%
2032 (forecast) $14.87 Bn +$1.18 Bn +78.2%
2033 (forecast) $16.15 Bn +$1.28 Bn +93.5%
2034 (forecast) $17.54 Bn +$1.39 Bn +110.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Hospice Care Market Analysis at a glance
Market size, 2025$8.35 Bn placeholder estimate
Forecast, 2034$17.54 Bn placeholder estimate
Growth (CAGR), 2025–20348.6% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsSetting, condition and end user (see all)
Key playersVITAS Healthcare, Amedisys Inc., Gentiva, Enhabit, Compassus (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Hospice Care Market Analysis Executive Summary

Hospice care gives comfort and support to people near the end of life and their families, mostly at home.

Key segments of the hospice Care market include setting (Home-Based, Hospice Facilities and Nursing Homes) and condition (Cancer, Dementia and Heart Disease).

Bar chart: Asia Pacific Hospice Care market size, 2024–2034, placeholder estimates. $7.69 Bn in 2024, $8.35 Bn in 2025 and $17.54 Bn in 2034, 8.6% CAGR.
Asia Pacific Hospice Care market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Hospice Care Market Dynamics

Market Growth Drivers

An ageing population, more people living with serious illness, family caregiver strain and payer focus on care at home are driving the hospice Care market.

Opportunity

Home-based models, technology for caregivers and value-based payment give the hospice Care market room to grow.

Market Restraints

Caregiver shortages, low payment rates, uneven quality and limited awareness of services hold back the hospice Care market.

Competitive Landscape for Hospice Care Market in APAC

The hospice Care market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hospice Care Market in APAC

Hospice Care in APAC: payment

How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[1], basic medical insurance (China)⁠[2], the Hospital Authority (Hong Kong)⁠[3], Ayushman Bharat PM-JAY (India)⁠[4], public health insurance (Japan)⁠[5], subsidised public care (Malaysia)⁠[6], Pharmac (New Zealand)⁠[7], PhilHealth (Philippines)⁠[8], MediShield Life (Singapore)⁠[9], the Universal Coverage Scheme (Thailand)⁠[10], JKN (BPJS Kesehatan) (Indonesia)⁠[11], out of pocket and Sehat Sahulat (Pakistan)⁠[12], National Health Insurance (South Korea)⁠[13] and social health insurance (Vietnam)⁠[14].

[1] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

[3] Hospital Authority. Checked 14 Nov 2026.

[4] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[5] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[6] Ministry of Health Malaysia. Checked 14 Nov 2026.

[7] Pharmac. Checked 14 Nov 2026.

[8] PhilHealth. Checked 14 Nov 2026.

[9] CPF Board, MediShield Life. Checked 14 Nov 2026.

[10] National Health Security Office. Checked 14 Nov 2026.

[11] BPJS Kesehatan. Checked 19 Nov 2026.

[12] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[13] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[14] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how hospice Care services are delivered and paid for in APAC. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hospice Care right now, from free public sources.

Patients

People aged 65 and over, % of people (World Bank)
CountryValueYear
Afghanistan2.42025
Australia18.12025
Bangladesh6.72025
China14.92025
Hong Kong23.72025
India7.42025
Indonesia7.52025
Japan30.02025
Malaysia8.02025
Myanmar7.52025
Nepal6.62025
New Zealand17.62025
Pakistan4.42025
Philippines5.72025
Singapore14.22025
South Korea20.32025
Thailand16.02025
Vietnam9.52025
Compare every country on the Public Health Dashboard

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hospice Care in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hospice Care market in Asia Pacific?
Placeholder estimate: about $8.35 Bn in 2025, rising to about $17.54 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hospice Care market in Asia Pacific growing?
Placeholder estimate: about 8.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hospice Care market report cover?
The report splits the market by setting (Home-Based, Hospice Facilities, Nursing Homes), condition (Cancer, Dementia, Heart Disease, Lung Disease) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Hospice Care market?
Key players include VITAS Healthcare, Amedisys Inc., Gentiva, Enhabit and Compassus.
What is driving the Hospice Care market?
An ageing population, more people living with serious illness, family caregiver strain and payer focus on care at home are driving the hospice Care market.
How much research is published on Hospice Care?
PubMed lists 1,951 papers on Hospice Care added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in APAC

See all

Related on home and long-term care and geriatric

See the topic